RSS

Medicines

In preparations for Brexit, the EMA has redistributed the UK’s product portfolio to other EU members and is not allocating any centralised marketing authorisation applications to the MHRA. We take a closer look… more

Opinion

Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence. more

Opinion

Vetter, has launched its Open Innovation Challenge campaign, aimed at developing innovative, future-focused and sustainable solutions for the injection of medicines that are better streamlined to user needs than current methods. more

News

A new study from the University of Eastern Finland, published in the European Journal of Clinical Pharmacology, has highlighted that there are differences in the availability of orphan medicines between different European countries. more

Analysis

NHS England has revealed that thousands of patients have benefited from the new CDF and as a result of discounts it has secured on eight treatments, savings of around £140 million should be generated over the course of the next five years more

News

The University of Liverpool’s Department of Molecular and Clinical Pharmacology has been awarded a Queen’s Anniversary Prize to recognise its work in the improvement of the safety and effectiveness of medicines. more

News

Research from the University of Warwick, evaluating how law can be employed to improve global access to essential medicines, has been published. more

News

The Healthcare Distribution Association (HDA UK) has raised concerns about the security of the supply of medicines in the UK following Brexit in response to the Health Select Committee’s inquiry. more

News

ABPI responds positively to a letter in the Financial Times from health secretary, Jeremy Hunt, and business secretary, Greg Clark, which lays out plans for the regulation of medicines in the UK after the country leaves the European Union. more

News

During the FIP 6th Pharmaceutical Sciences World Congress (PSWC) global representatives from across various pharmaceutical sectors discussed a plan for the discovery and development of new medicines based on systems biology more

News

During its March 2017 meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended six medicines for approval, including three orphans. more

News

GP and pharmaceuticals lawyer Dr Sam Samaratunga on the proposed changes to the UK market access for medicines more

News

The US FDA has approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s currently being administered levodopa/carbidopa and experiencing ‘off’ periods. more

News

Medicine and breast implants in the UK are to be printed with barcodes to help improve patient safety. more

News

The US Senate has passed the 21st Century Cure Act which could have significant implications for the regulation of both medicine and medical devices more

News

A new health management platform targeted towards medication adherence and proactive healthcare has been unveiled by digital health management company, Healthera. more

News

Farzad Henareh, Stericycle ExpertSolutions, discusses ‘fake Europe’ and the impact of counterfeit pharmaceutical products more

Opinion

EPM looks at medicine that is specifically created for individual patients more

Opinion

Indian regulators have banned Pfizer’s Corex cough syrup saying that it was likely to pose a risk to humans, according to Reuters more

News

Kushal Vyas, ELC Group, looks at barriers to generic entry in Europe more

Opinion